🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

6 recruiting trials

for Acute Myeloid Leukemia With FLT3/ITD Mutation

Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML NCT05024552Phase 11 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Gilteritinib, Vyxeos Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission NCT06824168Phase 264 sites📍 Birmingham📍 Los Angeles📍 Baltimore Daiichi Sankyo · Tests: Quizartinib High Dose, Quizartinib Low Dose A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants NCT07162116Phase 11 site📍 Zibo Shijiazhuang Yiling Pharmaceutical Co. Ltd · Tests: XY0206, Moxifloxacin (400 mg), XY0206 Placebo Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia NCT06022003Phase 220 sites📍 Amiens📍 Angers📍 Clamart French Innovative Leukemia Organisation · Tests: AzaCITIDine Oral Tablet, Xospata Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML NCT07259707Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: GVA + HDAC Consolidation & Gilteritinib Maintenance SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation NCT06222580Phase 14 sites📍 Chapel Hill📍 Columbus📍 Philadelphia Uma Borate · Tests: Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Gilteritinib, Revumenib, Echocardiography Test
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy